1. Stein DH. Scabies and pediculosis. Curr Opin Pediatr 1991;3:660-6.

2. Christopherson J. The epidemiology of scabies in Denmark, 1900 to 1975. Arch Dermatol 1978;114:747-50.

3. Church RE, Knowlesden J. Scabies in Sheffield: a family infestation. BMJ 1978;i:761.

4. Palicka P. The incidence and mode of scabies transmission in a district of Czechoslovakia (1961-1979). Folia Parasitol 1982;29:51-9.

5. Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol 1994;33:235-92.

6. Carslaw RW, Dobson RM, Hood AJK et al. Mites in the environment of cases of Norwegian scabies. Br J Dermatol 1975;92:333-7.

7. Walker GJA, Johnstone PW. Treating scabies. In: Cochrane Collaboration. Cochrane Library, Issue 4. Oxford: Update Software, 1999.

8. Amer M, El-Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int J Dermatol 1992;31:357-8.

9. Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990;7:67-73.

10. Taplin D, Meinking TL, Porcelain SL et al Permethrin 5% dermal cream: a new treatment of scabies. J Am Acad Dermatol 1986;15:995-1001.

11. Schultz MW, Gomez M, Hansen RC et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990;126:167-70.

12. Hanna NF, Clay JC, Harris JRW. Sarcoptes scabiei infestation treated with malathion liquid. Br J Vener Dis 1978;54:354.

13. Thianprasit M, Schuetzenberger R. Prioderm lotion in the treatment of scabies. Southeast Asian J Trop Med Public Health 1984;15:119-21.

14. Burgess I, Robinson RJ, Robinson J et al. Aqueous malathion 0-5% as a scabicide:clinical trial. BMJ 1986;292:1172.

15. Schmutz JL, Barbaud A, Trechot P. Intoxication aigue au lindane chez 3 enfants. Ann Dermatol Venereol 2001; 128:799.

16. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996;14:386-93.

17. Schinas V, Leontsinidis M, Alexopoulos A et al. Organochlorine pesticide residues in breast milk from southwest Greece: associations with weekly food consumption patterns of mothers. Arch Environ Health 2000;55:411-17.

18. Solomon BA, Haut SR, Carr EM et al. Neurotoxic reaction to lindane in an HIV-seropositive patient. An old medication's new problem. J Fam Pract 1995;40:291-6.

19. Cox R, Krupnick J, Bush N et al. Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention defecit hyperactivity disorder. J Miss State Med Assoc 2000;41:690-2.

20. Simon Giavarotti KA, Rodrigues L, Rodrigues T et al. Liver microsomal parameters related to oxidative stress and antioxidant systems in hyperthyroid rats subjected to acute lindane treatment. Free Radic Res 1998;29:35-42.

21. Videla LA, Arisi AC, Fuzaro AP et al. Prolonged phenobarbital pretreatment abolishes the early oxidative stress component induced in the liver by acute lindane intoxication. Toxicol Lett 2000;115:45-51.

22. Dick IP, Blain PG, Williams FM. The percutaneous absorption and skin distribution of lindane in man. I. In vivo studies. Hum Exp Toxicol 1997;16:645-51.

23. Dick IP, Blain PG, Williams FM. The percutaneous absorption and skin distribution of lindane in man. II. In vitro studies. Hum Exp Toxicol 1997;16:652-7.

24. Lange M, Nitzsche K, Zesch A. Percutaneous absorption of lindane in healthy volunteers and scabies patients.

Dependency of penetration kinetics in serum upon frequency of application, time and mode of washing. Arch Dermatol Res 1981;271:387-99.

25. Zesch A, Nitsche K, Lange M. Demonstration of the percutaneous resorption of a lipophilic pesticide and its possible storage in the human body. Arch Dermatol Res 1982;273:43-9.

26. Franz TJ, Lehman PA, Franz SF et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132:901-5.

27. Meinking TL, Taplin D. Safety of permethrin v lindane for the treatment of scabies. Arch Dermatol 1996; 132: 959-62.

28. Carapetis JR, Connors C, Yarmirr D et al. Success of a scabies control program in an Australian Aboriginal community. Pediatr Infect Dis J 1996;15:1056-7.

29. Hernandez-Perez E. Resistance to antiscabietic drugs. J Am Acad Dermatol 1983;8:121-2.

30. Roberts DT, ed. Lice & scabies. A health professional's guide to epidemiology and treatment. London: Public Health Laboratory Service, 2000:25.

31. Gulati PV, Singh KP. A family based study on the treatment of scabies with benzyl benzoate and sulphur ointment. Indian J Dermatol Venereol Lepr 1978;44: 269-73.

32. Srivastava BC, Chandra R, Srivastava VK et al. Epidemiological studies of scabies and community control. J Commun Dis 1980;12:134-8.

33. Amer M, El-Bayoumi, Rizik MK. Treatment of scabies: preliminary report. Int J Dermatol 1981;20:289-90.

34. Henderson C. Community control of scabies. Lancet 1991;337:1548.

35. Kenawi MZ, Morsy TA, Abdalla KF et al. Treatment of human scabies by sulfur and permethrin. J Egypt Soc Parasitol 1993;23:691-6.

36. Burns DA. The treatment of human ectoparasite infection. Br J Dermatol 1991; 125:89-93.

37. Avila-Romay A, Alvarez-Franco M, Ruiz-Maldonado R. Therapeutic efficacy, secondary effects, and patient acceptability of 105% sulfur in either pork fat or cold cream for the treatment of scabies. Pediatr Dermatol 1991;8:64-6.

38. Chowdhury SPR. Nitrofurazone in scabies. Lancet 1977;i:152.

39. Biagi F, Delgado Y, Garnica R. First therapeutic trials with thiabendazole cream. Int J Dermatol 1974;13:102-3.

40. Hernandez-Perez E. topically applied thiabendazole in the treatment of scabies. Arch Dermatol 1976; 112: 1400-1.

41. Orkin M, Maibach HI. Treatment of today's scabies. In: Orkin M, Maibach HI, eds. Cutaneous infestations and insect bites. New York: Marcel Dekker, 1986:103-8.

42. Temesvart E, Soos GY, Podamy B et al. Contact urticaria provoked by Balsam of Peru. Contact Dermatitis 1978;4:65-8.

43. Glaziou P, Cartel JL, Alzieu P et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993;44:331-2.

44. Plouvier B, Lemoine X, de Coninck P et al. Antabuse effect following topical application based on monosulfiram. Nouvelle Presse Med 1982;11:3209.

45. Blanc D, Deprez P. Unusual adverse reaction to an acaricide. Lancet 1990;335:1291-2.

46. Burgess I. Adverse reactions to monosulfiram. Lancet 1990;336:873.

47. Arditti J, Jouglard J. Cutaneous overdose with crotamiton and suspicion of methaemoglobinaemia. Bull Med Legale Toxicol 1978;21:661-2.

48. Macotela-Ruiz E, Pena-Gonzalez G. Treatment of scabies with oral ivermectin. Gac Med Mex 1993;129:210-15.

49. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000;42:236-40.

50. Chouela EN, Abeldano AM, Pellerano G et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999;135:651-5.

51. Pacque M, Munoz B, Greene BM et al. Safety of and compliance with community-based ivermectin therapy. Lancet 1990;335:1377-80.

52. De Sole G, Remme J, Awadzi K et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ 1989;67:707-19.

53. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997;349:1144-5.

54. Diazgranados JA, Costa JL. Deaths associated with ivermectin treatment of scabies. Lancet 1997;349:1698.

55. Corbet EL, Crossley I, Holton J et al. Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genltourln Med 1996;72:115-17.

56. Meinking TL, Taplin D, Hermida JL et al The treatment of scabies with ivermectin. N Engl J Med 1995;333:26-30.

57. Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med 1995;332:612.

0 0

Post a comment